Over the last 5 years, the ideas of evidence-based healthcare (EBH) have seized the policy agenda in the National Health Service (NHS) with remarkable rapidity. Clinical effectiveness has moved from being the concern of a few enthusiastic academics to being a mainstream issue for the NHS, spoken of by politicians, civil servants, managers and clinicians alike. EBH Many of the organizations we surveyed provided us with further information about their work on clinical effectiveness in the form of reports and other papers. We also used the information from the survey to identify nine health authorities and NHS trusts whom we then visited, to find out more about their work on clinical effectiveness.
Over the last 5 years, the ideas of evidence-based healthcare (EBH) have seized the policy agenda in the National Health Service (NHS) with remarkable rapidity. Clinical effectiveness has moved from being the concern of a few enthusiastic academics to being a mainstream issue for the NHS, spoken of by politicians, civil servants, managers and clinicians alike. EBH is an idea whose time has come.
The policy origins of our current preoccupation in the UK with EBH can be traced back to the growing recognition of the importance of research and development in the NHS which began in the late 1980s and early 1990s. The first ever research and development (R&D) strategy for the NHS was launched in 1991 1, with the bold aim of, in so many words, making the NHS an EBH service. In parallel with the development of the R&D strategy, the Department of Health has used Executive Letters2, strategy documents3 and the performance management arrangements for health authorities and NHS trusts (e.g. performance developmental framework for clinical effectiveness) to place the development of EBH on their agendas for action. The prominence accorded for 3 years running to clinical effectiveness in the annual Priorities and Planning Guidance issued by the Department of Health4, and the frequency of other communications on the same topic demonstrate the importance with which the issue is viewed nationally. EBH is and will continue to be a high policy priority.
SURVEY OF PROGRESS IN THE NHS IN ENGLAND
Recognizing that the national policy guidance on improving clinical effectiveness set an ambitious agenda, we set out to assess what progress health authorities and NHS trusts had made in translating the policy into a reality. We wanted to explore how far they had got in implementing real changes in strategies, structures, service provision and clinical practice that moved them closer towards purchasing or providing EBH-to see whether the reality of purchasing and providing healthcare had kept up with the rhetoric of national policy on We also asked NHS trusts and health authorities whether they had developed a formal strategy for improving clinical effectiveness and moving towards EBH. A strategy for improving clinical effectiveness and developing EBH can meet a number of important needs. The process of developing a strategy helps to build a coalition of support for improving clinical effectiveness, and highlights existing activities which contribute to its aims. Adopting a formal strategy makes a visible organizational commitment to the issue, and raises the priority attached to it by people throughout the organization. The strategy helps to establish a shared, coherent and consistent vision of what needs to be achieved and how it will be done. It also establishes a benchmark against which progress can be monitored and reviewed. Although we recognized that the existence of a written strategy document was no guarantee of appropriate action, we felt that it at least demonstrated that the issues of improving clinical effectiveness had been discussed, and that a local agenda for action had been created.
We were surprised to find that only just over half of health authorities (56%) and less than a third of NHS trusts (32%) reported that they had some form of written strategy for clinical effectiveness. Again, this suggests that health authorities have made more progress in this area than NHS trusts. But it also indicates that the majority of NHS trusts and almost half of health authorities have yet to take what might be regarded as the first important step towards improving clinical effectiveness. Having said that, many health authorities and NHS trusts indicated that although no formal strategy had been adopted, one was being developed.
FROM STRATEGY TO ACTION
Having a strategy for clinical effectiveness is one thing; putting it into effect is quite another. We found health authorities and NHS trusts using a wide range of ways and means aimed at fostering an evidence-based approach to healthcare and changing clinical practice. We grouped the fairly disparate activities we found under nine broad headings: NHS Executive as part of the PACE (promoting action on clinical effectiveness) programme. Demonstration projects have some attractive characteristics. Because of their limited scale and scope, they are relatively easy to set up, do not demand much in the way of resources, and do not require much of the rest of the organization. Since they are often sited with enthusiastic clinicians and focused on relatively clear-cut and manageable clinical topics their chances of successful clinical change are high. They therefore serve as a way to demonstrate the feasibility and value of new concepts like EBH care.
However, demonstration projects may also have their drawbacks. They can be an excuse for the rest of the organization to do nothing but watch and wait as the demonstration project takes place. Quite small projects can consume a disproportionate amount of time and effort given their scale and likely impact. When projects come to an end, it is easy for old habits and patterns of practice to reassert themselves, leaving little to show they were ever there. Most importantly, demonstration projects do not necessarily help organizations to understand how to roll out an innovation like clinical effectiveness across other departments and service areas. It seems that demonstration projects have real value in the early stages of improving clinical effectiveness. However, it is essential that health authorities and NHS trusts have a strategy for moving forward beyond such projects to take the ideas of EBH to the rest of the organization. The PACE programme terms this transition 'moving from project to mainstream'6, and suggests that for improvements in effectiveness resulting from demonstration projects to be sustained and replicated, a wider process of organizational change is needed.
USING EFFECTIVE HEALTH CARE BULLETINS
There are an increasing number of sources of information on clinical effectiveness which health authorities and NHS trusts should be using to improve the effectiveness of the care they provide. But with regular publications like the Effective Health Care Bulletin, Bandolier, and Evidence-based Medicine, the rising number of completed systematic reviews contained in the Cochrane Library, and the evidence published in journals and other literature, it is difficult to keep abreast of the latest information, let alone to read, appraise, digest and act on it all. We were, therefore, interested to know how health authorities and NHS trusts were coping with this tide of information, and how they managed its dissemination.
In our surveys, we asked both health authorities and NHS trusts about how they handled one widely available source of information on clinical effectiveness-the Effective Health Care bulletins produced by the NHS Centre for Reviews and Dissemination at the University of York. We asked who received the bulletins, who disseminated them, and who followed them up to check that any appropriate action had been taken. The results are summarized in Figure 1 .
The Effective Health Care bulletins are mailed to all health authorities and NHS trusts in the UK. Each health authority receives over 30 copies, sent directly to chief executives, directors of public health, directors of primary care, and other key staff by the NHS Centre for Reviews and Dissemination. Each NHS trust receives at least 20 copies, again mailed directly to key staff. It was therefore reassuring but unsurprising to find that virtually all health authorities and trusts reported that they received this important source of information on clinical effectiveness. Nevertheless, the 7% of NHS trusts who either said they did not receive the bulletins or did not know whether they did or not must give some cause for concern.
We asked whether someone was responsible for distributing the Effective Health Care bulletins within the organization, to the individuals or departments who needed to know about or make use of their recommendations. Slightly fewer health authorities and NHS trusts reported that they had arrangements for distributing the bulletins in place-about 13% of NHS trusts and 17% of health authorities did not. We were somewhat surprised by the response from health authorities and trusts when we asked whether someone was responsible for following up the Effective Health Care bulletins to see what action had been taken. About 63% of health authorities and only 41% of NHS trusts said that this role had been assigned to someone. In other words, at many health authorities and at most NHS trusts, no arrangements to follow up the bulletins had been made. We used our survey to study the use made of three Effective Health Care bulletins issued about a year earlier.
* Daycase cataract surgery. The bulletin on the management of cataract7, published in February 1996, explored the evidence for the effectiveness of cataract surgery, and recommended that at least 80% of cataract surgery patients should be operated on as day cases. It suggested that day-case patient outcomes were equally as good as those who had their operation as inpatients, and pointed out that day cases cost about 30% less. At the time, it asserted, only about 20% of cataract operations in the UK were being done as day cases. * Surgical interventionsfor benign prostatic hyperplasia (BPH).
The bulletin on the management of BPH8 made a number of recommendations about the threshold for surgical intervention and the use of 'watchful waiting'. It recommended that the transurethral incision of prostate (TUIP) should replace the transurethral resection of prostate (TURP) as the treatment of choice for men requiring surgery, as it was just as effective, but used fewer resources and was less hazardous for patients. * Use of pressure relieving aids. The bulletin on the prevention and treatment of pressure sores9 indicated that most of the equipment available for preventing and treating pressure sores (such as special beds and mattresses) had not been reliably evaluated and no 'best buy' could be recommended. It recommended that rather than using expensive, high-tech pressure relieving beds, most patients at raised risk of developing pressure sores should be placed on a low pressure foam mattress.
For each bulletin, we asked health authorities and NHS trusts a parallel set of questions, concerning: whether they had received the bulletin in question; whether it had been discussed with clinicians in the specialty concerned; whether local clinicians agreed with the bulletin's recommendations; whether current practice already complied with the guidelines; and whether practice had changed since the bulletin had been received. We also invited comments from respondents on the Effective Health While virtually all health authorities recalled receiving the bulletin on cataract surgery, only about 75% of NHS trusts said they had seen it. About 60% of health authorities said they had discussed this bulletin with their local NHS trusts who provided ophthalmology services. However, only 33% of trusts said they had discussed it with their health authority. It is difficult to reconcile these two reports. The majority of both health authorities and trusts thought that current The argument about whether or not we should give much greater attention to the effectiveness of health services has largely been won. At a national level, considerable progress has also been made in developing the R&D infrastructure needed to support an EBH service, through the creation of new research programmes focused more closely on the research needs of the NHS, and the establishment of dissemination centres like the Cochrane Collaboration and the NHS Centre for Reviews and Dissemination.
Though many health authorities had taken the issues of clinical effectiveness to heart, and some had developed strategies, structures and action plans intended to ensure that evidence was used properly in decision making throughout the organization, some had not. It seemed from our survey that progress had been rather slower at NHS trusts. Some trusts were making real efforts to introduce the ideas of clinical effectiveness, but many had yet to progress beyond the early stages of raising awareness and generating debate. Our survey analysis was based on responses from 42% of trusts, and responders are likely to have had more to report than non-responders. It therefore seems probable that most NHS trusts still have some way to go before they can genuinely claim to have taken improving clinical effectiveness seriously, or to have made efforts to become evidence-based providers of health services.
